Kevin Burton, the snooping entrepreneur with a buggy website, has a new problem: Tailrank, his Web news aggregator, is supposed to deliver users the latest dope. But recently, it's been doing so a bit too literally, serving up drug-spam ads rather than the usual assortment of tech headlines. Tipster Micah Lerner writes: "If I funded Tailrank, I would be very upset right now. How will they get investors now?" Oh, I don't know, Micah: Will his investors really be that mad? Or just grateful for the leads on where to score?

Contact information for this author is not available.